CRT-Guanfacine for SPD

NCT02524899 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

45

Enrollment

OTHER

Sponsor class

Conditions

Schizotypal Personality Disorder
SPD

Interventions

BEHAVIORAL: Cognitive Remediation Therapy
DRUG: Guanfacine
DRUG: Placebo

Sponsor

Icahn School of Medicine at Mount Sinai

Collaborators

[object Object]